TRPM6
Transient receptor potential cation channel subfamily M member 6
Also known as: CHAK2, FLJ22628, HOMG, HSH, TRPM6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BX84
- Gene
- TRPM6
- Ensembl
- ENSG00000119121
- Chromosome
- 9
- Canonical length
- 2022 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels
OverviewNCBI Gene
This gene is predominantly expressed in the kidney and colon, and encodes a protein containing an ion channel domain and a protein kinase domain. It is crucial for magnesium homeostasis, and plays an essential role in epithelial magnesium transport and in the active magnesium absorption in the gut and kidney. Mutations in this gene are associated with hypomagnesemia with secondary hypocalcemia. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
2022 residues, UniProt reviewed canonical sequence.
>Q9BX84|TRPM6
1 MKEQPVLERL QSQKSWIKGV FDKRECSTII PSSKNPHRCT PVCQVCQNLI RCYCGRLIGD
61 HAGIDYSWTI SAAKGKESEQ WSVEKHTTKS PTDTFGTINF QDGEHTHHAK YIRTSYDTKL
121 DHLLHLMLKE WKMELPKLVI SVHGGIQNFT MPSKFKEIFS QGLVKAAETT GAWIITEGIN
181 TGVSKHVGDA LKSHSSHSLR KIWTVGIPPW GVIENQRDLI GKDVVCLYQT LDNPLSKLTT
241 LNSMHSHFIL SDDGTVGKYG NEMKLRRNLE KYLSLQKIHC RSRQGVPVVG LVVEGGPNVI
301 LSVWETVKDK DPVVVCEGTG RAADLLAFTH KHLADEGMLR PQVKEEIICM IQNTFNFSLK
361 QSKHLFQILM ECMVHRDCIT IFDADSEEQQ DLDLAILTAL LKGTNLSASE QLNLAMAWDR
421 VDIAKKHILI YEQHWKPDAL EQAMSDALVM DRVDFVKLLI EYGVNLHRFL TIPRLEELYN
481 TKQGPTNTLL HHLVQDVKQH TLLSGYRITL IDIGLVVEYL IGRAYRSNYT RKHFRALYNN
541 LYRKYKHQRH SSGNRNESAE STLHSQFIRT AQPYKFKEKS IVLHKSRKKS KEQNVSDDPE
601 STGFLYPYND LLVWAVLMKR QKMAMFFWQH GEEATVKAVI ACILYRAMAH EAKESHMVDD
661 ASEELKNYSK QFGQLALDLL EKAFKQNERM AMTLLTYELR NWSNSTCLKL AVSGGLRPFV
721 SHTCTQMLLT DMWMGRLKMR KNSWLKIIIS IILPPTILTL EFKSKAEMSH VPQSQDFQFM
781 WYYSDQNASS SKESASVKEY DLERGHDEKL DENQHFGLES GHQHLPWTRK VYEFYSAPIV
841 KFWFYTMAYL AFLMLFTYTV LVEMQPQPSV QEWLVSIYIF TNAIEVVREI CISEPGKFTQ
901 KVKVWISEYW NLTETVAIGL FSAGFVLRWG DPPFHTAGRL IYCIDIIFWF SRLLDFFAVN
961 QHAGPYVTMI AKMTANMFYI VIIMAIVLLS FGVARKAILS PKEPPSWSLA RDIVFEPYWM
1021 IYGEVYAGEI DVCSSQPSCP PGSFLTPFLQ AVYLFVQYII MVNLLIAFFN NVYLDMESIS
1081 NNLWKYNRYR YIMTYHEKPW LPPPLILLSH VGLLLRRLCC HRAPHDQEEG DVGLKLYLSK
1141 EDLKKLHDFE EQCVEKYFHE KMEDVNCSCE ERIRVTSERV TEMYFQLKEM NEKVSFIKDS
1201 LLSLDSQVGH LQDLSALTVD TLKVLSAVDT LQEDEALLAK RKHSTCKKLP HSWSNVICAE
1261 VLGSMEIAGE KKYQYYSMPS SLLRSLAGGR HPPRVQRGAL LEITNSKREA TNVRNDQERQ
1321 ETQSSIVVSG VSPNRQAHSK YGQFLLVPSN LKRVPFSAET VLPLSRPSVP DVLATEQDIQ
1381 TEVLVHLTGQ TPVVSDWASV DEPKEKHEPI AHLLDGQDKA EQVLPTLSCT PEPMTMSSPL
1441 SQAKIMQTGG GYVNWAFSEG DETGVFSIKK KWQTCLPSTC DSDSSRSEQH QKQAQDSSLS
1501 DNSTRSAQSS ECSEVGPWLQ PNTSFWINPL RRYRPFARSH SFRFHKEEKL MKICKIKNLS
1561 GSSEIGQGAW VKAKMLTKDR RLSKKKKNTQ GLQVPIITVN ACSQSDQLNP EPGENSISEE
1621 EYSKNWFTVS KFSHTGVEPY IHQKMKTKEI GQCAIQISDY LKQSQEDLSK NSLWNSRSTN
1681 LNRNSLLKSS IGVDKISASL KSPQEPHHHY SAIERNNLMR LSQTIPFTPV QLFAGEEITV
1741 YRLEESSPLN LDKSMSSWSQ RGRAAMIQVL SREEMDGGLR KAMRVVSTWS EDDILKPGQV
1801 FIVKSFLPEV VRTWHKIFQE STVLHLCLRE IQQQRAAQKL IYTFNQVKPQ TIPYTPRFLE
1861 VFLIYCHSAN QWLTIEKYMT GEFRKYNNNN GDEITPTNTL EELMLAFSHW TYEYTRGELL
1921 VLDLQGVGEN LTDPSVIKPE VKQSRGMVFG PANLGEDAIR NFIAKHHCNS CCRKLKLPDL
1981 KRNDYSPERI NSTFGLEIKI ESAEEPPARE TGRNSPEDDM QLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRPM6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- rectum: 16 nTPM
- colon: 12 nTPM
- small intestine: 7.4 nTPM
- duodenum: 6.6 nTPM
- spinal cord: 3.3 nTPM
- bone marrow: 2.4 nTPM
Single-cell type
- distal convoluted tubule cells: 1,018 nCPM
- renal connecting tubule cells: 276 nCPM
- neutrophils: 238 nCPM
- colonocytes: 220 nCPM
- neutrophil progenitors: 138 nCPM
- endometrial luminal cells: 132 nCPM
Immune cell
- basophil: 23 nTPM
- neutrophil: 7.5 nTPM
- eosinophil: 2.4 nTPM
- NK-cell: 0.5 nTPM
- naive B-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
Brain region
- white matter: 15 nTPM
- medulla oblongata: 11 nTPM
- pons: 10 nTPM
- basal ganglia: 9 nTPM
- midbrain: 9 nTPM
- thalamus: 8.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRPM6.
Disease | AllUniProt
Conditions TRPM6 is implicated in, by any mechanism.
- Hypomagnesemia 1 (HOMG1) MIM:602014
Disease | GeneticClinVar
67 pathogenic / likely-pathogenic of 973 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.61
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- calcium ion transport
- magnesium ion transmembrane transport
- monoatomic cation transmembrane transport
- protein tetramerization
- response to toxic substance
Molecular functions
- ATP binding
- calcium channel activity
- calcium ion transmembrane transporter activity
- magnesium ion transmembrane transporter activity
- metal ion binding
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alpha-type protein kinase, alpha-kinase domain
- Ion transport domain
- Protein kinase-like domain superfamily
- TRPM, tetramerisation domain
- TRPM, tetramerisation domain superfamily
- TRPM, SLOG domain
- Transient receptor potential cation channel M
- TRPM-like domain
- Ion transport protein
- Alpha-kinase family
- Tetramerisation domain of TRPM
- SLOG in TRPM
- TRPM2-like domain
- Transient receptor potential cation channel subfamily M member 6, alpha-kinase domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRPM6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRPM6 as an antibody target. Whether an autoantibody or antibody against TRPM6 could matter depends on whether native TRPM6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRPM6 is annotated at the cell surface, where native TRPM6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRPM6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...